• AG-126: From ERK Mechanism to Translational Insight

  2026-08-08

  AG-126, also known as Tyrphostin AG-126, offers translational researchers a pharmacological way to interrogate ERK1/2 signaling alongside circuit-level mechanisms of repetitive behavior. This article connects the Neuroligin 1–D2-MSN study to experimental questions around ERK phosphorylation, PKC-linked excitability, cytokine signaling, and inflammation, while clearly separating established evidence from testable hypotheses. It also outlines assay design, controls, competitive positioning, and the limitations that must be addressed before ERK modulation can be meaningfully evaluated in neurobehavioral models.

• Carbenoxolone disodium: Practical Lab Guide

  2026-08-07

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor and gap junction communication probe for cell- and tissue-based studies of glucocorticoid handling, Cx43 signaling, and related physiology. This guide covers preparation, controls, and interpretation boundaries; it should not be treated as an in vivo efficacy protocol or a selective target-validation reagent.

• AMG 487: Applied CXCR3 Antagonist Workflows in Macrophage Re

  2026-08-07

  AMG 487 enables researchers to dissect the CXCL10–CXCR3 axis with unmatched selectivity, redefining workflows for studying macrophage polarization and acute lung injury. Leveraging cutting-edge insights into LAMP1-controlled signaling, this guide delivers practical protocol enhancements and troubleshooting tips for robust, reproducible results.

• OTUD7B Controls IRF3 Degradation via Autophagy in Antiviral

  2026-08-06

  This study identifies OTUD7B as a deubiquitinase that modulates antiviral immunity by promoting autophagic degradation of IRF3 through selective deubiquitination of SQSTM1/p62. These findings provide new insight into the interplay between autophagy and innate immune signaling and highlight potential targets for modulating immune responses.

• L-Phenylephrine: Transforming Mechanistic Cardiovascular Res

  2026-08-06

  This thought-leadership article explores how L-Phenylephrine, a selective adrenergic α1A receptor agonist, is revolutionizing translational research in cardiovascular and neural biology. Integrating mechanistic insight with strategic guidance, it contextualizes the compound’s role in dissecting sex differences in hypertension development, clarifies protocol parameters, critiques the competitive research landscape, and charts a visionary outlook for future applications. By bridging robust in vitro and in vivo evidence with evolving translational needs, this analysis goes beyond standard product descriptions to offer implementable recommendations and critical reflections for research leaders.

• BAPTA Calcium Chelator (SKU B7187): Data-Driven Solutions fo

  2026-08-05

  This article explores how BAPTA (2,2',2'',2'''-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanetriyl))tetraacetic acid) (SKU B7187) addresses key challenges in calcium-dependent cell viability and apoptosis research. Drawing on quantitative literature and recent environmental toxicology studies, it demonstrates the molecule’s utility, protocol parameters, and reliability. Researchers will learn how to leverage SKU B7187 to improve workflow consistency and interpretability in calcium signaling assays.

• Carboplatin: Platinum-Based DNA Synthesis Inhibitor Workflow

  2026-08-05

  Carboplatin empowers preclinical oncology research with robust, reproducible inhibition of DNA synthesis across diverse cancer models. This article translates advanced findings—including resistance mechanisms and stem cell targeting—into actionable protocols and troubleshooting strategies for maximizing your research impact.

• CX-4945 (Silmitasertib): CK2 Inhibition and ECE-1c-Driven Ag

  2026-08-04

  Explore how CX-4945 (Silmitasertib) enables precise, mechanistic dissection of CK2-regulated cancer pathways, with a focus on ECE-1c stabilization and stemness in lung cancer. This article provides a deeper analytical perspective on CK2 inhibition for cancer research, uniquely linking molecular findings to assay choices.

• Elobixibat Hydrate: Beyond Constipation—Metabolic and Transl

  2026-08-04

  Discover how Elobixibat hydrate, a leading ileal bile acid transporter inhibitor, offers metabolic, gastrointestinal, and translational benefits extending beyond chronic idiopathic constipation. This in-depth review unveils underexplored mechanisms and practical guidance for advanced research and clinical protocols.

• Radicicol: Translating Hsp90 Inhibition into Metabolic and I

  2026-08-03

  Explore how Radicicol, a potent Hsp90 inhibitor, serves as a strategic lever for translational researchers targeting obesity, cancer, and inflammatory models. This article delves into Radicicol’s mechanistic footprint—bridging kinase inhibition, adipogenic blockade, and apoptosis enhancement—and offers practical guidance for experimental design, protocol optimization, and the roadmap from cellular models to pathophysiological insight. By integrating recent advances in non-canonical thermogenesis and cross-domain inflammation strategies, we clarify how Radicicol unlocks new territory beyond standard inhibitor paradigms.

• Tubastatin A: Unlocking HDAC6 Inhibition for Advanced Diseas

  2026-08-03

  Explore the unique capabilities of Tubastatin A, a potent HDAC6 inhibitor, in refining disease models and experimental outcomes. This article delves deeper than existing guides, focusing on mechanistic precision, protocol optimization, and translational insight for research in cancer, neuroprotection, and inflammation.

• Phosbind Biotin: Next-Gen Phosphorylation Detection in Signa

  2026-08-02

  Discover how Phosbind Biotin enables ultra-sensitive, sequence-independent detection of phosphorylated proteins and unlocks new experimental possibilities in signal transduction pathway research. This article dives deeper into assay decision-making and mechanistic insight than existing resources.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-08-01

  The reference study reveals that naturally occurring angiotensin peptides, including short N- and C-terminal fragments, significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings connect cardiovascular peptide biology to viral receptor interactions, highlighting new research avenues for both hypertension and COVID-19 mechanisms.

• Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Apoptosis Det

  2026-07-31

  The Annexin V-Cy5/DAPI Apoptosis Kit from APExBIO delivers rapid, dual-parameter apoptosis and necrosis detection—empowering researchers with actionable, high-content cellular readouts. Its one-step protocol and robust sensitivity streamline mechanistic studies of mitochondrial apoptosis, especially in translational leukemia research.

• 2-D08: Precision SUMOylation Inhibition for Advanced Cancer

  2026-07-31

  Explore the unique mechanism of 2-D08 (2’,3’,4’-trihydroxyflavone) as a selective sumoylation inhibitor in cancer research. This article unpacks its scientific advantages and workflow protocols, offering new insights and a practical edge for posttranslational modification studies.

16017 records 1/1068 page Next 12345 下5页 Last page